GAA
TXG icon

Green Alpha Advisors’s 10x Genomics TXG Stock Holding History

Green Alpha Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$532K Sell
5,890
-2,482
-30% -$145K 0.36% 71
2026
Q2 		$321K Buy
+8,372
New +$219K 0.22% 83
2026
Q1 		– Sell
-10,153
Closed -$166K – 114
2025
Q4 		$166K Sell
10,153
-11,115
-52% -$168K 0.15% 103
2025
Q3 		$249K Sell
21,268
-1,188
-5% -$15.5K 0.24% 84
2025
Q2 		$260K Sell
22,456
-1,514
-6% -$13.8K 0.25% 87
2025
Q1 		$209K Sell
23,970
-757
-3% -$9.54K 0.22% 95
2024
Q4 		$355K Buy
+24,727
New +$390K 0.28% 106
2024
Q2 		– Sell
-5,713
Closed -$214K – 142
2024
Q1 		$214K Buy
5,713
+60
+1% +$2.64K 0.16% 130
2023
Q4 		$316K Sell
5,653
-2,834
-33% -$123K 0.23% 129
2023
Q3 		$350K Sell
8,487
-2,311
-21% -$120K 0.27% 117
2023
Q2 		$603K Buy
10,798
+436
+4% +$23.6K 0.4% 98
2023
Q1 		$578K Sell
10,362
-345
-3% -$16.1K 0.41% 96
2022
Q4 		$390K Buy
10,707
+890
+9% +$29.1K 0.32% 109
2022
Q3 		$280K Sell
9,817
-1,676
-15% -$63.9K 0.24% 128
2022
Q2 		$520K Buy
11,493
+3,492
+44% +$181K 0.12% 126
2022
Q1 		$609K Buy
8,001
+1,049
+15% +$91.8K 0.41% 101
2021
Q4 		$1.04M Buy
6,952
+664
+11% +$102K 0.7% 69
2021
Q3 		$915K Buy
6,288
+863
+16% +$148K 0.63% 82
2021
Q2 		$1.06M Buy
5,425
+3,977
+275% +$720K 0.72% 59
2021
Q1 		$262K Buy
+1,448
New +$250K 0.26% 103

Other funds holding TXG

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Green Alpha Advisors's TXG Position: Q3 2026 in Review

Green Alpha Advisors reduced its 10x Genomics (TXG) stake by 30% in Q3 2026, selling an estimated $145K and leaving 5,890 shares worth $532K. The position accounts for 0.36% of the portfolio, ranked #71.

Green Alpha Advisors first reported a position in TXG in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.06M in Q2 2021. 9 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Green Alpha Advisors held 5,890 shares of 10x Genomics worth $532K as of Q3 2026.
  • Green Alpha Advisors sold 2,482 10x Genomics shares in Q3 2026, an estimated $145K.
  • 10x Genomics made up 0.36% of Green Alpha Advisors's portfolio in Q3 2026, its #71 holding.
  • Green Alpha Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 20 quarters since.
  • Green Alpha Advisors's 10x Genomics position peaked at $1.06M in Q2 2021.
  • 9 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.